In March 2025, the company introduced new strategies to get a direct-to-customer presenting of its Wegovy weight loss drug. The company founded a fresh pharmacy, identified as NovoCare, which might demand prospects $499 every month for usage of the drug, under fifty percent the expense of the drug by other pharmaceutical distribution networks.[53]B